Brief: Senzime Secures Sales In 16 Hospitals In Q4 of 2021
Jan 3 (Reuters) - Senzime AB (publ) SEZI.ST :
* SENZIME SECURED SALES IN 16 HOSPITALS IN Q4, 2021
* AT END OF DECEMBER , NUMBER OF ONGOING OR PLANNED TRIALS
AMOUNTED TO 74 HOSPITALS WITH POTENTIAL OF 1,150 TETRAGRAPH
SYSTEMS
* DURING Q4 OF 2021, SENZIME SECURED TETRAGRAPH SALES IN 16
HOSPITALS WORLDWIDE.
Source text for Eikon: ID:nMFNr00qL
Further company coverage: SEZI.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Senzime AB (publ)
See all newsBrief: Senzime Tetragraph System Receives Anvisa Approval For Sale In Brazil
Brief: Senzime Secures Contract With U.S. Hospital
Brief: Senzime Gets Additional FDA Class II 510(K) Clearance For Tetragraph System
Brief: Senzime's TetraGraph System Contracted On Three GPO Agreements In U.S.
Sweden's Senzime Q1 sales dip on weak US markets, strong krona